All 39 GNOM Holdings
The GNOM ETF is a fund that invests in companies focused on gene editing and genomic research. It aims to provide exposure to innovative technology in the healthcare sector. The fund holds stocks of companies involved in genetic testing, gene therapy, and other related technologies. The goal of the GNOM ETF is to capture potential growth in the genomics industry.
**Charts show 1 year
Rank | Ticker | Company | Weight | Country | Market Cap | Industry |
---|---|---|---|---|---|---|
1 | NTRA | Natera Inc | 10.04% | United States | $5.64b | Diagnostics & Research |
2 | RARE | Ultragenyx | 5.76% | United States | $2.97b | Biotechnology |
3 | SRPT | Sarepta Therapeutics Inc | 5.23% | United States | $10.76b | Biotechnology |
4 | CRSP | Crispr Therapeutics AG | 5.22% | United States | $3.83b | Biotechnology |
5 | A | Agilent Technologies Inc | 5.17% | United States | $39b | Diagnostics & Research |
6 | BMRN | Biomarin Pharmaceutical Inc | 5.1% | United States | $17.35b | Biotechnology |
7 | TXG | 10x Genomics | 5.07% | United States | $4.96b | Health Information Services |
8 | 1548 | Genscript Biotech Corp | 4.89% | Hong Kong | Biotechnology | |
9 | QGEN | Qiagen NV | 4.82% | United States | $10.00b | Diagnostics & Research |
10 | TECH | Bio-Techne Corp | 4.31% | United States | $12.33b | Biotechnology |
11 | ALNY | Alnylam Pharmaceuticals Inc | 3.72% | United States | $25b | Biotechnology |
12 | ARWR | Arrowhead Pharmaceuticals Inc | 3.71% | United States | $3.85b | Biotechnology |
13 | VRTX | Vertex Pharmaceuticals Inc | 3.31% | United States | $83b | Biotechnology |
14 | BNTX | BioNTech SE | 3.3% | United States | $27b | Biotechnology |
15 | RCKT | Rocket Pharmaceuticals Inc | 3.13% | United States | $1.39b | Biotechnology |
16 | MYGN | Myriad Genetics Inc | 3.11% | United States | $1.70b | Diagnostics & Research |
17 | VCYT | Veracyte Inc | 3.02% | United States | $1.59b | Biotechnology |
18 | ILMN | Illumina Inc | 2.68% | United States | $33b | Diagnostics & Research |
19 | BEAM | Beam Therapeutics Inc | 2.52% | United States | $2.21b | Biotechnology |
20 | GILD | Gilead Sciences Inc | 2.42% | United States | $104b | Drug Manufacturers-General |
21 | NTLA | Intellia Therapeutics Inc | 2.09% | United States | $3.19b | Biotechnology |
22 | MRNA | Moderna Inc | 1.94% | United States | $51b | Biotechnology |
23 | RGNX | Regenxbio Inc | 1.34% | United States | $799.73m | Biotechnology |
24 | 4974 | Takara Bio Inc | 1.1% | Japan | Biotechnology | |
25 | CDNA | Caredx Inc | 0.93% | United States | $418.66m | Diagnostics & Research |
26 | FLGT | Fulgent Genetics Inc | 0.92% | United States | $859.00m | Diagnostics & Research |
27 | EDIT | Editas Medicine Inc | 0.81% | United States | $544.86m | Biotechnology |
28 | PACB | Pacific Biosciences of California | 0.64% | United States | $2.46b | Medical Devices |
29 | ALLO | Allogene Therapeutics Inc | 0.57% | United States | $784.62m | Biotechnology |
30 | VERV | Verve Therapeutics Inc | 0.54% | United States | $977.58m | Biotechnology |
31 | STOK | Stoke Therapeutics Inc | 0.53% | United States | $396.00m | Biotechnology |
32 | BNGO | Bionano Genomics Inc | 0.49% | United States | $221.50m | Medical Instruments & Supplies |
33 | CRBU | Caribou Biosciences Inc | 0.44% | United States | $259.91m | Biotechnology |
34 | QURE | Uniqure NV | 0.43% | United States | $908.64m | Biotechnology |
35 | TSVT | 2 | 0.35% | United States | $329.82m | Biotechnology |
36 | BLUE | Bluebird bio Inc | 0.16% | United States | $378.76m | Biotechnology |
37 | SGMO | Sangamo Therapeutics Inc | 0.15% | United States | $271.26m | Biotechnology |
38 | NSTG | NanoString Technologies Inc | 0.02% | United States | $420.65m | Medical Instruments & Supplies |
39 | NVTA | Invitae Corp | 0.01% | United States | $335.99m | Diagnostics & Research |